L & S Advisors’s Boston Scientific BSX Stock Holding History

L & S Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-91,029	Closed	-$8.89M	–	371
2025 Q3	$8.89M	Buy	91,029 +18,939	+26%	+$1.96M	0.85%	35
2025 Q2	$7.74M	Buy	72,090 +8,525	+13%	+$863K	0.77%	35
2025 Q1	$6.41M	Sell	63,565 -35,145	-36%	-$3.54M	0.79%	35
2024 Q4	$8.82M	Buy	98,710 +17,191	+21%	+$1.51M	0.97%	26
2024 Q3	$6.83M	Buy	81,519 +49,410	+154%	+$3.89M	0.71%	44
2024 Q2	$2.47M	Sell	32,109 -59,283	-65%	-$4.34M	0.28%	94
2024 Q1	$6.26M	Buy	+91,392	New	+$5.88M	0.71%	50

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

L & S Advisors's BSX Position: Q4 2025 in Review

L & S Advisors sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 91,029 shares — an estimated $8.89M sold.

L & S Advisors first reported a position in BSX in Q1 2024 and held it in 7 quarters. The position peaked at $8.89M in Q3 2025. 1,791 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

L & S Advisors reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
L & S Advisors sold 91,029 Boston Scientific shares in Q4 2025, an estimated $8.89M.
L & S Advisors first reported a position in Boston Scientific in Q1 2024 and held it in 7 quarters.
L & S Advisors's Boston Scientific position peaked at $8.89M in Q3 2025.
1,791 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on L & S Advisors's 13F filing for Q4 2025, filed 5 Feb 2026.